Cite
Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers.
MLA
Jo, Jinhee, et al. “Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers.” Journal of Infectious Diseases, vol. 229, no. 1, Jan. 2024, pp. 273–81. EBSCOhost, https://doi.org/10.1093/infdis/jiad537.
APA
Jo, J., Hu, C., Begum, K., Wang, W., Le, T. M., Agyapong, S., Hanson, B. M., Ayele, H., Lancaster, C., Alam, M. J., Gonzales-Luna, A. J., & Garey, K. W. (2024). Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers. Journal of Infectious Diseases, 229(1), 273–281. https://doi.org/10.1093/infdis/jiad537
Chicago
Jo, Jinhee, Chenlin Hu, Khurshida Begum, Weiqun Wang, Thanh M Le, Samantha Agyapong, Blake M Hanson, et al. 2024. “Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers.” Journal of Infectious Diseases 229 (1): 273–81. doi:10.1093/infdis/jiad537.